Investors in Life Science

TRICAPITAL is a leading early-stage investment organisation founded in 2004 as Tweed Renaissance Investors Capital. From those early days, as our name suggests, our members took a particular interest in investments based in the Scottish Borders. The TRICAPITAL syndicate today is significantly more geographically widespread, operating across Scotland as a whole in partnership with Scottish Enterprise – providing us with direct access to match funding from the Scottish Co-Investment Fund for eligible investments. Our international and diverse membership cohort brings a wide range of current and relevant skills to our portfolio companies distinguishing us a customer centric, investor led investment house.

Selvedge Venture is a venture capital advisory and management firm headquartered in London, UK. Specializing in providing strategic guidance and management services, Selvedge Venture supports early-stage and growth-stage companies in navigating the complex landscape of venture capital. With a focus on fostering innovation and sustainable growth, Selvedge Venture aims to empower entrepreneurs and startups to achieve their full potential in the competitive global market.

European Equity Partners specializes in providing capital to high-growth companies in Northern Europe seeking external funding. As a dedicated investment firm, European Equity Partners focuses on identifying and supporting promising businesses with innovative ideas and scalable business models. Their investment strategy is centered around fostering growth and maximizing potential through strategic financial support and operational guidance. By leveraging their expertise and network, European Equity Partners aims to empower entrepreneurs and drive sustainable economic development in Northern Europe. They play a pivotal role in fueling innovation and entrepreneurship by offering tailored financial solutions and fostering long-term partnerships with ambitious companies poised for expansion.

Eurovestech PLC is an AIM-listed pan-European development capital fund that specializes in investing in high-technology enterprises. The firm focuses on identifying and supporting innovative companies across Europe with high growth potential, particularly in sectors such as technology and digital media. Eurovestech provides strategic development capital to help these enterprises accelerate their growth, expand their market presence, and achieve their strategic objectives. As a publicly listed company on the AIM market, Eurovestech offers investors the opportunity to participate in the growth of promising high-tech businesses through transparent and regulated investment vehicles. The firm's investment strategy emphasizes active management and value creation, aiming to maximize shareholder value while supporting the development of transformative technologies and businesses.

Rosetta Capital Limited operates as a private equity and venture capital firm specializing in direct secondary investments. The firm focuses on acquiring direct stakes in private companies from existing shareholders, providing liquidity and growth capital to support these businesses. Rosetta Capital's investment strategy involves identifying attractive opportunities in established companies with strong growth potential and sustainable business models. By leveraging its expertise in direct secondary transactions, the firm aims to generate value and foster growth within its portfolio companies. Rosetta Capital plays a crucial role in the secondary market, facilitating transactions that enable shareholders to realize value while positioning portfolio companies for continued success and expansion.

Utopia aims to bridge the gap between the perception of collective well-being and its actual implementation by investing in high-growth startups in the Life Sciences sector. They believe that the future of startups lies in prioritizing collective well-being across the value chain. By focusing on these investments, Utopia seeks to revitalize the investment landscape while promoting genuine well-being in the economy, reflecting their commitment to this challenging goal.

Padda health is a VALUE CREATOR VENTURE CAPITAL that invests in innovative start-ups and SMEs in the healthcare area, sustaining them with a value generating skills network, through Padda Innovation Town. Padda health possesses a vision of open innovation on a global scale, while featuring the relationships usually connected with a family office. Padda health moves quickly, creating and providing value, turning start-ups into great game changers through something worth much more than money, i.e. human capital. Padda health is a start-up enabler that, by making use of a network of professionals in the fields of marketing, HR, procurement, legal and finance, aims to support the key areas during all the development stages of the start-ups

At Korify, the team focuses on investing in innovative and visionary companies that have the potential to shape the future they envision. Korify Capital is focused on three investment strategies: Distributed development companies, Enabling technologies and domain-specific platforms.

Planet First Partners is a growth equity platform that invests in and partners with disruptive entrepreneurs to scale tech-enabled businesses that combine a purpose-driven mission, profitable growth, and a people-centric culture. As an Article 9 fund, Planet First Partners applies rigorous methodology for sustainable investing and commits to always follow the highest standards and strictest criteria. Founded in 2020, Planet First Partners is made up of a highly experienced, qualified team of investment and sustainability experts focused on maximising and optimising sustainability. The team is complemented by a mission-aligned advisory board, made up of global business and political leaders.

Start Codon focuses on translating disruptive research into successful startups, emphasizing a unique approach influenced by Cambridge's innovation ecosystem. The firm identifies promising technologies and research with commercial potential, providing seed funding, mentoring, and access to networks. Start Codon aims to accelerate the development of early-stage biotech and healthcare startups, contributing to breakthrough innovations in these fields. Through its tailored support and strategic guidance, Start Codon plays a crucial role in bridging the gap between scientific discovery and market-ready solutions.

Medicxi is a leading investment firm specializing in the life sciences sector. They are dedicated to supporting innovation and advancement in biotechnology, pharmaceuticals, and healthcare. Medicxi collaborates with pioneering entrepreneurs and talented management teams to accelerate the development of breakthrough therapies, medical technologies, and healthcare solutions. With a strategic focus on early and late-stage investments, Medicxi aims to address significant medical challenges and improve patient outcomes globally. Their team combines deep scientific and investment expertise to identify promising opportunities and provide critical support throughout the growth phases of portfolio companies.

Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that aim to advance healthcare and biotechnology. The firm supports early-stage ventures as well as growth-stage companies, providing critical capital, strategic guidance, and industry expertise to drive their development and success. Monograph Capital's investments span across biotech, pharmaceuticals, medical devices, and other areas within the life sciences field, aiming to contribute to breakthrough discoveries, therapies, and medical advancements. Through its strategic investments, Monograph Capital plays a crucial role in accelerating innovation and improving health outcomes globally.